Mirtazapine Enantiomers in Blood and Cerebrospinal Fluid
Authors:
- Pierre BaumannPBPierre Baumann
- Michèle Jonzier-PereyMJMichèle Jonzier-Perey
- Erik PausEPErik Paus
- Georg NikischGNGeorg Nikisch
- 1 January 2006
- journal article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 54 (3) , 179-181
Abstract
Little information exists on the concentrations of recent antidepressants and their metabolites in cerebrospinal fluid (CSF). Using a stereoselective method, we measured plasma and CSF levels of mirtazapine (MIR), N-demethylmirtazapine and 8-OH-MIR in 3 depressed patients treated with racemic MIR (45 mg/day) for 4 weeks. S-(+)-MIR is considered to be the antidepressant enantiomer, but only R-(–)-MIR reached measurable concentrations in CSF. For R-(–)-MIR, the CSF/plasma ratio varied between 0.08 and 0.31. Further studies are needed to test the hypothesis that there are possible differences in the transport mechanisms of the enantiomers of MIR at the blood-CSF barrier.Keywords
This publication has 12 references indexed in Scilit:
- Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopramInternational Journal of Neuropsychopharmacology, 2005
- The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in PsychiatryPharmacopsychiatry, 2004
- Chirality in the New Generation of AntidepressantsTherapeutic Drug Monitoring, 2004
- Stereoselective Metabolism of Citalopram in Plasma and Cerebrospinal Fluid of Depressive PatientsJournal of Clinical Psychopharmacology, 2004
- Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceClinical Pharmacology & Therapeutics, 2004
- Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruptionBiological Psychiatry, 2003
- Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical SettingClinical Pharmacokinetics, 2002
- Clinical Pharmacokinetics of MirtazapineClinical Pharmacokinetics, 2000
- Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapineInternational Clinical Psychopharmacology, 1995
- Active Hydroxymetabolites of AntidepressantsClinical Pharmacokinetics, 1995